首页> 外文期刊>Experimental Animals >Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
【24h】

Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9

机译:利用带有Cas9切口酶和FokI-dCas9的crRNA / tracrRNA的CRISPR / Cas9系统高效生产突变小鼠

获取原文
           

摘要

The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice.
机译:CRISPR / Cas9系统是用于生产转基因动物的强大基因组编辑工具。为了生产突变小鼠,将嵌合单向导RNA(sgRNA)克隆到质粒载体中,并将​​sgRNA和Cas9的混合物显微注射到受精卵中。使用CRISPR / Cas9系统进行基因操作的一个问题是可能会产生脱靶效应。为了简化由CRISPR / Cas9系统引起的脱靶效应风险较低的突变小鼠的生产,我们证明了使用化学合成的CRISPR RNA(crRNA),反式激活crRNA(tracrRNA)可以有效地获得转基因小鼠,通过向受精卵内显微注射,以及修饰的Cas9s(例如切口酶版本和FokI融合的催化失活的Cas9)。使用这种方法,不再需要将sgRNA克隆到质粒载体中,这可以实现突变小鼠的高通量生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号